AAVPT Veterinary Drug Regulatory Life Cycle (A to Z)
Appendix 1: Commonly Used Acronyms
Appendix 2: Summary of CVM Guidances for Industry
Monday February 28, 2011
AM session: Introductions, Overviews, General Information
- 9:00 9:15AM Products Regulated By CVM Vitolis Vengris
- 9:15 9:45AM Introduction to the Course, Drug Approval Philosophy, ADUFA/AGDUFA Steve Vaughn
- 9:45 10:00AM - Comparison to human drug development Mike Murphy
- 10:30 10:45 AM What Happens When a Submission Gets to DCU? Beth Canter
- 10:45 11:20AM Administrative Issues Beth Luddy
- 11:20 11:40 AM Patent term restoration vs. exclusivity Urvi Desai
- 1:00 1:30PM Communication with ONADE Angela Clarke
- :30 2:00PM Pre-Approval Process, INAD vs. NADA Barb Leotta
PM Session: Chemistry, Manufacturing, and Controls Technical Section
- 2:00 2:30PM The Big Picture of a Long-Term Commitment James Nitao
- 2:45 3:15PM Overview of Question based Review (QbR) (QbR-Drug Product example) Becky Owen/ Elizabeth Cormier
- 3:15 3:45PM Pre-approval GMP facility inspections, Scheduling and Coordinating Robin Stone
- 3:45 4:15PM Lifecycle based approach Sudesh Kamath
Tuesday, March 1, 2011
AM Session: Effectiveness Technical Section
- 8:00 8:30AM Using PK as a tool in product development and regulation Marilyn Martinez
- 8:30 8:50AM Dosage characterization Sanja Modric
- 8:50 9:20AM Effectiveness Overview Linda Wilmot
- 9:20 9:50AM Statistical Overview Jean Recta
- 9:50 10:20AM Effectiveness evaluation for production drugs (HFV-120): Danielle Sholly
- 10:20 10:35AM BREAK
- 10:35 11:05AM Effectiveness evaluation for therapeutic drugs for food animals (HFV-130) Michelle Kornele
- 11:05 11:35AM Effectiveness Evaluation for therapeutic drugs for companion animals HFV-110) Ed Chen
PM Session: Target Animal Safety (TAS) Technical Section
- 1:00 1:20PM Intro to Safety Principles & Pharmacological and Toxicological characterization Laura Hungerford
- 1:20 1:40PM TAS Overview Cindy Burnsteel
- 1:40 2:00PM Understanding Regulations Concerning Electronic Records Vernon Toelle
- 2:00 2:20PM TAS Statistical Overview Vicki Lancaster
- 2:20 2:50PM TAS Evaluation for production drugs (HFV-120) Amey Adams
- 3:10 3:35PM TAS Evaluation for therapeutic drugs for food animals (HFV-130) Emily Smith
- 3:35 4:05PM Evaluation of TAS for therapeutic drugs for companion animals (HFV-110) A'ndrea Van Schoick
- 4:05 4:35PM Use of PK in support of TAS Marilyn Martinez
Wednesday March 2, 2011
- 8:00 8:20AM - Human abuse potential assessment and scheduling Germaine Connolly
AM Session: Human Food Safety (HFS) Technical Section
- 8:20 9:00AM Toxicology Tong Zhou
- 9:00 9:45AM Residue Chemistry Julia Oriani
- 9:45 10:30AM Microbial Food Safety Ruby Singh and Silvia Pineiro
- 10:45 11:15AM Post-Approval Violative Residues Debbie Cera
AM Session II: Environmental Safety
- 11:15 11:45 - Environmental Safety Wesley Hunter
PM Session I: Minor Technical Sections, FOI Summary, NADA
- 1:00 1:20PM Labeling Ann Stohlman
- 1:20 1:40PM All Other Information Sharon Chase
- 1:40 2:00PM Freedom of Information Summary Harlan Howard
- 2:00 2:20PM Administrative NADA Laurie Hanna
- 3:00 - 3:20PM - Nomenclature Considerations for Defining Veterinary Products - Martinez and Modric.
PM Session II: Generics
- 3:00 3:30PM The Generic Drug Approval Process - Katherine Weld & Sharon Ricciardo
- 3:30 4:00PM Suitability Petitions Ken Harshman
- 4:00 4:30PM Biowaiver requests Ian Hendricks
Thursday March 3, 2011
- 8:00 8:40AM MUMS Meg Oeller
AM Session I: Animal Feeds
- 8:40 9:10AM Non-Medicated Feed: Regulatory oversight of animal food Geoff Wong and Tom Hendricks
- 9:10 10:00AM Medicated Feeds Overview Dragan Momcilovic
- Post Approval Activities Jason Smith
- Medicated Feeds Licensing Program Isabel Pocurull
AM Session II: Compliance
- 10:30 10:45AM Compliance Overview Neal Bataller (Slides not provided)
- 10:45 11:05 CPGM 7371.001 Marea Harmon
- 11:05 11:25AM BIMO Vernon Toelle
- 11:25 11:45AM Recalls Dillard Woody
PM Session: Surveillance
- 1:00 1:15PM Overview of post-approval reporting requirements Tom Modric
- 1:15 1:40PM Quantity marketed Jinhee Lee & Beth Anne Grove
- 1:40 1:55 PM Electronic registration & drug listing Charise Kasser
- 1:55 2:25PM Introduction to medication error prevention Linda Kim-Jung
- 2:25 2:55PM - Pharmacovigilance Tina Burgess
- 3:25 3:55PM Post-approval experience, labeling issues Stacey Shults
- 3:55 4:25PM Advertising issues, effectiveness claims Mike Murphy
- 4:25 4:55PM Communicating risk & fair balance in promotional material Dottie McAdams
Friday March 4, 2011
AM Session I: Research at CVM
- 8:00 9:20AM Office of Research Mike Myers
AM Session II: Biotechnology
- 9:35 10:00AM Biotechnology Brinda Dass
- 10:15 10:40AM Biotechnology continued Malini Mansharamani
AM Session II: Miscellaneous Topics
- 10:40 11:00AM Opportunity for Public Input Diane Heinz
- 11:00 11:20AM Unapproved Drug Initiative Beth Luddy
- 11:20 11:40AM CVM Website Virtual Tour Laura Bradbard
